Companies
Markets
Tech
Media
companies
News
Economy
Your Money, Your America
Davos
markets
premarkets
dow 30
After-Hours
market movers
fear & greed
world markets
investing
markets now
before the bell
romans' numeral
Sectors
Quest's Profitable Moment
tech
Pacific
Work Transformed
Living in the Future
Innovate
Our Driverless Future
Tech Business
Culture
Future
Startups
Media
Success
Personal Finance
Money Essentials
Tax Guide
New Rules for Retirement
Boss Files
Fresh Money
Entrepreneurs
American Opportunity
Calculators
More...
SURGE
Newsletters
Alerts: Sign up/Manage
Interactives
Contact Us
Closed Captioning
Follow us:
Search News
Symbol Matches
Symbol Starts With
Company Matches
U.S.
International
Switzerland
ZIOPHARM Oncology Inc
(NASDAQ:ZIOP)
Add to Watch List
Set Alert
4.31
Delayed Data
As of
4:00pm ET
+0.03
/
+0.70%
Today’s Change
3.33
Today
|||
52-Week Range
7.88
+4.11%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Insider trading
|
Institutional ownership
Largest transactions by value over
3 month
6 month
1 year
Name
Type
Date
Shares
traded
Share
price
Transaction
value
Since
transaction
Cooper Laurence James Neil
Chief Executive Officer
Sale
5/05/2017
132,000
$7.12
$939.8K
-39.89%
Belbel Caesar J
Sale
12/30/2017
31,450
$4.14
$130.2K
-3.60%
Lebel Francois /ziopharm/
Executive Vice President-Research & Development
Sale
12/30/2017
31,450
$4.14
$130.2K
-3.60%
Cooper Laurence James Neil
Chief Executive Officer
Sale
12/30/2017
26,178
$4.14
$108.4K
-3.60%
Belbel Caesar J
Sale
6/01/2017
16,666
$6.11
$101.8K
-29.95%
Belbel Caesar J
Sale
12/31/2017
21,667
$4.14
$89.7K
-3.60%
Lebel Francois /ziopharm/
Executive Vice President-Research & Development
Sale
12/31/2017
21,667
$4.14
$89.7K
-3.60%
Fowler Wyche Jr
Director
Sale
6/12/2017
13,980
$5.47
$76.5K
-21.76%
Weiser Michael
Director
Sale
6/12/2017
13,300
$5.47
$72.8K
-21.76%
Brennan Murray F
Director
Sale
6/12/2017
13,300
$5.47
$72.8K
-21.76%
Page
of 4